HUM

Humana Inc. Common Stock (HUM)

Stock · NYSE · Health Care

$385.54as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 29, 2026

Humana partners with DaVita on kidney care for MA members. Humana has entered a value-based care agreement with DaVita to coordinate care for its Medicare Advantage members with advanced chronic kidney disease (stages 3B-5). The arrangement aims to manage treatment for patients before they reach end-stage renal disease, a costly and complex condition for health plans. Separately, Humana was mentioned in Diamond Hill's Q2 2026 Small-Mid Cap portfolio review, indicating continued institutional interest in the stock. The partnership is relevant for Humana given its large Medicare Advantage membership and the high costs associated with late-stage kidney care.

Active signals

No technical signal is currently active for this symbol.

Support level
$170.98
Industry
Medical Specialities

About HUM

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Med…

Sector
Health Care
Industry
Medical Specialities
Employees
67,060

Fundamentals

1-day range
$386.61$397
Market cap
$44.97B
P/E (trailing)
36.09
P/E (forward)
23.70
EPS (trailing)
$10.56
Dividend yield
0.68%
Beta
0.76
Avg. volume
1.40M
Ex-dividend date
June 26, 2026
Dividend pay date
July 31, 2026
52-week range
$163.11$428.88
Next earnings: November 6, 2026 · EPS estimate $-0.95Before Openconfirmed

How Humana Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$129.66BNet Income$1.19B (1%)Other$112.78B (87%)SG&A$15.45B (12%)Tax$250.00M (0%)HUM

Source: 10-K filed Feb 19, 2026 · via SEC EDGAR / Finnhub

Forecasts

23 analyst ratings

Buy 49%
Hold 46%
Sell 6%
1-year price forecast
High
$513
+33.1%
Median
$415
+7.6%
Low
$280
-27.4%

Humana Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • HUM
    Humana Inc. Common Stock
    $385.54
    ▼ 1.81%
    Market cap $44.97BP/E 36.09
    $163.11$428.88
  • NTRA
    Natera Inc. Common Stock
    $326.47
    ▼ 3.61%
    Market cap $38.72BP/E
    $157.43$343.18
  • CNC
    Centene Corporation Common Stock
    $64.77
    ▼ 0.86%
    Market cap $31.50BP/E
    $28.24$69.36
  • ILMN
    Illumina Inc. Common Stock
    $215.65
    ▼ 5.29%
    Market cap $29.98BP/E 34.73
    $88$231.81
  • GH
    Guardant Health Inc. Common Stock
    $161.76
    ▼ 4.01%
    Market cap $21.31BP/E
    $53.4$176.58
  • CI
    The Cigna Group Common Stock
    $278.88
    ▲ 0.44%
    Market cap $74.53BP/E 11.52
    $239.51$315.47
  • MOH
    Molina Healthcare Inc Common Stock
    $199.88
    ▲ 0.57%
    Market cap $10.17BP/E 1249.59
    $121.06$244.89

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
98.4K
Disposed
15.8K

Institutional Ownership

March 31, 2026

Total shares held
112.71M
Total value held
$19.22B
Institutional holders
774
Top holders this quarter
  • Unknown11.38M
  • Unknown10.20M
  • Unknown7.84M
  • Unknown5.47M
  • Unknown5.45M
  • Unknown4.48M
  • Unknown3.73M
  • Unknown3.33M
  • Unknown2.97M
  • Unknown2.86M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.